Formula Growth’s Medallia, Inc. MDLA Stock Holding History

Formula Growth’s Portfolio MDLA Stock Details MDLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-89,179	Closed	-$3.01M	–	163
2021 Q2	$3.01M	Sell	89,179 -55,018	-38%	-$1.58M	0.41%	80
2021 Q1	$4.02M	Buy	+144,197	New	+$5.35M	0.58%	55

Other funds holding MDLA

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Formula Growth's MDLA Position: Q3 2021 in Review

Formula Growth sold out of Medallia, Inc. (MDLA) in Q3 2021, closing a stake of 89,179 shares — an estimated $3.01M sold.

Formula Growth first reported a position in MDLA in Q1 2021 and held it in 2 quarters. The position peaked at $4.02M in Q1 2021. 208 funds tracked by Wall St. Rank hold MDLA as of Q3 2021.

Formula Growth reported no remaining Medallia, Inc. position as of Q3 2021 after selling out during the quarter.
Formula Growth sold 89,179 Medallia, Inc. shares in Q3 2021, an estimated $3.01M.
Formula Growth first reported a position in Medallia, Inc. in Q1 2021 and held it in 2 quarters.
Formula Growth's Medallia, Inc. position peaked at $4.02M in Q1 2021.
208 funds tracked by Wall St. Rank held Medallia, Inc. as of Q3 2021.

Based on Formula Growth's 13F filing for Q3 2021, filed 12 Nov 2021.